Travere Therapeutics to Report Third Quarter 2025 Financial Results
Go back to Travere Therapeutics to Report Third Quarter 2025 Financial Results| (NASDAQ: TVTX) | Delayed: 65.67 -1.85 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.52 | 52 Week High | $ | |||
| Open | $67.27 | 52 Week Low | $ | |||
| Day High | $67.45 | P/E | N/A | |||
| Day Low | $65.37 | EPS | $ | |||
| Volume | 808,519 | |||||

